SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000162
Filing Date
2021-05-10
Accepted
2021-05-10 16:15:23
Documents
14
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20210510.htm   iXBRL 8-K 48862
2 EX-99.1 lbph-20210510-ex99_1.htm EX-99.1 163208
3 GRAPHIC img192275205_0.jpg GRAPHIC 11946
  Complete submission text file 0000950170-21-000162.txt   367444

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20210510.xsd EX-101.SCH 2269
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20210510_pre.xml EX-101.PRE 11700
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20210510_lab.xml EX-101.LAB 18014
7 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20210510_htm.xml XML 4946
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 21907387
SIC: 2834 Pharmaceutical Preparations